Showing results (141-150 of 3,125) with videos related to
Sort By:
Pageof 313
NIDA Research Monograph|January 1, 1997
Introduction--the validity of self-reported drug use: improving the accuracy of survey estimatesL Harrison, A HughesBritish Journal of Perioperative Nursing : the Journal of the National Association of Theatre Nurses|March 15, 2002
Electrosurgical smoke plume. Is it harmful to staff?A Hughes, J HughesBiochemical Pharmacology|March 1, 1989
Specific binding of 125I SCH 23982, a selective dopamine (D1) receptor ligand to plasma membranes derived from human kidney cortexA Hughes, P SeverNature Medicine|August 1, 1996
Alternatively spliced mdm2 transcripts with loss of p53 binding domain sequences: transforming ability and frequent detection in human cancerI Sigalas, A H Calvert, J J Anderson, et al.Cancer Chemotherapy and Pharmacology|January 1, 1991
The pharmacokinetics of the quinazoline antifolate ICI D 1694 in mice and ratsD I Jodrell, D R Newell, W Gibson, et al.British Journal of Cancer|May 1, 1995
Molecular characterisation of two cell lines selected for resistance to the folate-based thymidylate synthase inhibitor, ZD1694S J Freemantle, A L Jackman, L R Kelland, et al.Journal of Medicinal Chemistry|March 6, 1992
Syntheses and thymidylate synthase inhibitory activity of the poly-gamma-glutamyl conjugates of N-[5-[N-(3,4-dihydro-2-methyl-4-oxoquinazolin-6-ylmethyl)-N-methylamino ]-2-thenoyl]-L-glutamic acid (ICI D1694) and other quinazoline antifolatesG M Bisset, K Pawelczak, A L Jackman, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|February 17, 2006
Mechanisms of early brain injury after subarachnoid hemorrhageJulian Cahill, W Julian Cahill, John W Calvert, et al.Cancer Treatment Reports|November 1, 1983
Phase II study of JM8, a new platinum analog, in advanced ovarian carcinomaB D Evans, K S Raju, A H Calvert, et al.Pageof 313